Automated Good Manufacturing Practice-Compatible CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells for Clinical Treatment of beta-Hemoglobinopathies

DSpace Repository

Automated Good Manufacturing Practice-Compatible CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells for Clinical Treatment of beta-Hemoglobinopathies

Author: Urena-Bailen, Guillermo; Block, Milena; Grandi, Tommaso; Aivazidou, Faidra; Quednau, Jona; Krenz, Dariusz; Daniel-Moreno, Alberto; Lamsfus-Calle, Andres; Epting, Thomas; Handgretinger, Rupert; Wild, Stefan; Mezger, Markus
Tübinger Autor(en):
Ureña-Bailén, Guillermo
Handgretinger, Rupert
Mezger, Markus
Lamsfus Calle, Andrés
Daniel Moreno, Alberto
Published in: Crispr Journal (2023), Bd. 6, H. 1, S. 5-16
Verlagsangabe: Mary Ann Liebert, Inc
Language: English
Full text: http://dx.doi.org/10.1089/crispr.2022.0086
ISSN: 2573-1599
DDC Classifikation: 570 - Life sciences; biology
610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)